Computational drug discovery (AI/ML + FEP + MD) for antimicrobial, peptide, and GPCR targets; UiO host for 1–2 MSCA-DN doctoral candidates.

My research at the University of Oslo, Department of Pharmacy, focuses on computational drug discovery for therapeutically important targets, including G protein-coupled receptors, peptide-binding receptors, and antimicrobial systems. I combine AI/ML virtual screening with structure-based ligand design, GPU-accelerated molecular dynamics, and rigorous absolute and relative binding free-energy methods (ABFE, RBFE, FEP) to triage hit candidates and quantitatively rank leads.